Volume 31, Issue 5
Full Paper

Preparation of Tris(2-aminoethyl)amine-Cross-Linked Cyclodextrin-Based Porous Nanospheres and Their Application as Drug Delivery Systems

Youqing Wang

Youqing Wang

National Center for Nanoscience and Technology, Beijing 100190, China

Search for more papers by this author
Yanchao Zhao

Yanchao Zhao

National Center for Nanoscience and Technology, Beijing 100190, China

Search for more papers by this author
Baohang Han

Corresponding Author

Baohang Han

National Center for Nanoscience and Technology, Beijing 100190, China

National Center for Nanoscience and Technology, Beijing 100190, China, 0086-10-82545576Search for more papers by this author
First published: 21 May 2013
Citations: 2

Abstract

Cyclodextrins (CDs) show functionality, biocompatibility, and host-guest inclusion capacity with a variety of molecules. These unique properties offer great potential for the exploitation of CDs as drug delivery systems. An easy, green, and effective synthetic approach was described to develop CD-based porous nanospheres (CDPNSs) with a size distribution from 100 to 400 nm. A new cross-linker tris(2-aminoethyl)amine was used to cross-link modified β-CD at room temperature. The resulting CD-based polymers (CDPs) were reshaped from a random morphology into a spherical shape during a dialysis process, and CDPNSs were obtained. The morphologies of CDPs and CDPNSs were observed with scanning electron microscopy. The average diameter and the size distribution of CDPNSs were determined by dynamic light scattering. The structures of the resulting products were characterized by using Fourier transform infrared spectroscopy, 1H NMR spectroscopy, solid-state 13C CP/MAS NMR spectroscopy, and X-ray diffraction. Furthermore, a study was conducted on drug loading and in vitro release behavior of CDPNSs, which was monitored by ultraviolet spectroscopy. The prepared CDPNSs show the potential as drug delivery systems.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.